Bioanalytical Systems Revenue 2006-2018 | BASI
Bioanalytical Systems revenue from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Bioanalytical Systems Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $26 |
| 2017 | $24 |
| 2016 | $20 |
| 2015 | $23 |
| 2014 | $25 |
| 2013 | $22 |
| 2012 | $28 |
| 2011 | $33 |
| 2010 | $29 |
| 2009 | $32 |
| 2008 | $42 |
| 2007 | $40 |
| 2006 | $43 |
| 2005 | $42 |
| Bioanalytical Systems Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q4 2018 | $9 |
| Q3 2018 | $6 |
| Q2 2018 | $6 |
| Q1 2017 | $5 |
| Q4 2017 | $6 |
| Q3 2017 | $6 |
| Q2 2017 | $6 |
| Q1 2016 | $6 |
| Q4 2016 | $5 |
| Q3 2016 | $5 |
| Q2 2016 | $5 |
| Q1 2015 | $5 |
| Q4 2015 | $5 |
| Q3 2015 | $6 |
| Q2 2015 | $6 |
| Q1 2014 | $6 |
| Q4 2014 | $6 |
| Q3 2014 | $6 |
| Q2 2014 | $6 |
| Q1 2013 | $6 |
| Q4 2013 | $6 |
| Q3 2013 | $6 |
| Q2 2013 | $5 |
| Q1 2012 | $6 |
| Q4 2012 | $7 |
| Q3 2012 | $7 |
| Q2 2012 | $7 |
| Q1 2011 | $8 |
| Q4 2011 | $8 |
| Q3 2011 | $8 |
| Q2 2011 | $8 |
| Q1 2010 | $8 |
| Q4 2010 | $7 |
| Q3 2010 | $8 |
| Q2 2010 | $7 |
| Q1 2009 | $6 |
| Q4 2009 | $9 |
| Q3 2009 | $8 |
| Q2 2009 | $7 |
| Q1 2008 | $8 |
| Q4 2008 | $9 |
| Q3 2008 | $11 |
| Q2 2008 | $10 |
| Q1 2007 | $11 |
| Q4 2007 | $7 |
| Q3 2007 | $11 |
| Q2 2007 | $11 |
| Q1 2006 | $11 |
| Q4 2006 | $11 |
| Q3 2006 | $10 |
| Q2 2006 | $12 |
| Q1 2005 | $10 |
| Q4 2005 | $12 |
| Q3 2005 | $11 |
| Q2 2005 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.014B | $0.026B |
| Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $101.646B | 22.71 |
| Intuitive Surgical (ISRG) | United States | $62.797B | 59.11 |
| Edwards Lifesciences (EW) | United States | $37.165B | 37.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.805B | 16.10 |
| IDEXX Laboratories (IDXX) | United States | $18.132B | 49.24 |
| ABIOMED (ABMD) | United States | $16.324B | 107.76 |
| Hologic (HOLX) | United States | $13.485B | 20.39 |
| DexCom (DXCM) | United States | $13.192B | 0.00 |
| Teleflex (TFX) | United States | $13.146B | 29.84 |
| Varian Medical Systems (VAR) | United States | $12.050B | 30.10 |
| STERIS (STE) | United Kingdom | $10.343B | 26.58 |
| Masimo (MASI) | United States | $6.869B | 44.54 |
| Penumbra (PEN) | United States | $5.368B | 324.10 |
| LivaNova (LIVN) | United Kingdom | $4.892B | 31.40 |
| Globus Medical (GMED) | United States | $4.712B | 29.54 |
| Integra LifeSciences Holdings (IART) | United States | $4.349B | 21.19 |
| Wright Medical Group (WMGI) | Netherlands | $3.986B | 0.00 |
| Cantel Medical (CMD) | United States | $3.532B | 34.84 |
| Inogen (INGN) | United States | $3.029B | 65.39 |
| Tandem Diabetes Care (TNDM) | United States | $2.955B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.678B | 22.41 |
| Glaukos (GKOS) | United States | $2.417B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.298B | 20.71 |
| OPKO Health (OPK) | United States | $1.677B | 0.00 |
| Nevro (NVRO) | United States | $1.462B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.305B | 207.82 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.220B | 35.25 |
| Luminex (LMNX) | United States | $1.161B | 53.14 |
| Accelerate Diagnostics (AXDX) | United States | $1.073B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.067B | 0.00 |
| Intersect ENT (XENT) | United States | $1.019B | 0.00 |
| CryoLife (CRY) | United States | $0.999B | 108.12 |
| Natus Medical (BABY) | United States | $0.922B | 19.24 |
| Mesa Laboratories (MLAB) | United States | $0.897B | 36.71 |
| AngioDynamics (ANGO) | United States | $0.871B | 28.27 |
| ViewRay (VRAY) | United States | $0.765B | 0.00 |
| Veracyte (VCYT) | United States | $0.754B | 0.00 |
| AxoGen (AXGN) | United States | $0.673B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.632B | 0.00 |
| TransEnterix (TRXC) | United States | $0.596B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.475B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.445B | 0.00 |
| Si-Bone (SIBN) | United States | $0.438B | 0.00 |
| Accuray (ARAY) | United States | $0.433B | 0.00 |
| Fluidigm (FLDM) | United States | $0.405B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.372B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.353B | 0.00 |
| Neuronetics (STIM) | United States | $0.316B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.304B | 0.00 |
| Sientra (SIEN) | United States | $0.298B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.298B | 47.80 |
| IRadimed (IRMD) | United States | $0.290B | 61.72 |
| Nuvectra (NVTR) | United States | $0.247B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.239B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.238B | 41.38 |
| Helius Medical Technologies (HSDT) | United States | $0.179B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.137B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.121B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.093B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.085B | 0.00 |
| EDAP TMS (EDAP) | France | $0.082B | 0.00 |
| ConforMIS (CFMS) | United States | $0.080B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.074B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.067B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Vermillion (VRML) | United States | $0.060B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.056B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.049B | 0.00 |
| Electromed (ELMD) | United States | $0.048B | 25.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.042B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.038B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.034B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.033B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.031B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.13 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.011B | 0.00 |
| Avinger (AVGR) | United States | $0.010B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
| InspireMD (NSPR) | Israel | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
